- Abbott Laboratories (NYSE:ABT) is scheduled to announce Q2 earnings results on Thursday, July 22nd, before market open.
- The consensus EPS Estimate is $1.02 (+78.9% Y/Y) and the consensus Revenue Estimate is $9.67B (+31.9% Y/Y).
- Adjusted gross margin estimate is 56.1%.
- Over the last 2 years, ABT has beaten EPS estimates 88% of the time and has beaten revenue estimates 63% of the time.
- Over the last 3 months, EPS estimates have seen 0 upward revisions and 18 downward. Revenue estimates have seen 0 upward revisions and 14 downward.
- Seeking Alpha contributor Stephen Simpson, last month, opined that "with the pandemic receding, Abbott should see volumes pick up in other businesses".
- The company's shares, which have gained more than 8% YTD, fell ~3% premarket in reaction to Q1 topline and FY forecast numbers that missed estimates during its quarterly results on April 20.
Abbott Laboratories Q2 2021 Earnings Preview
Recommended For You
More Trending News
About ABT Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| ABT | - | - |
| Abbott Laboratories | ||